Author: Kaitlyn Grosse

Funding

Alpine Immune Sciences Raising $100M in Public Offering

• Posted onSeptember 27, 2022 Last Updated: September 27, 2022
• By: Kaitlyn Grosse

Funding

Institute for Systems Biology Awarded $13M to Study Administering Cancer Drugs in Succession

• Posted onSeptember 27, 2022 Last Updated: September 27, 2022
• By: Kaitlyn Grosse

Funding

Allen Institute Lands Over $173M for Brain Research

• Posted onSeptember 27, 2022 Last Updated: September 27, 2022
• By: Kaitlyn Grosse

News

Tasso Earns FDA Clearance for its Home Blood Collection Device for Telehealth Tests

• Posted onSeptember 21, 2022 Last Updated: September 21, 2022
• By: Kaitlyn Grosse

News

Allen Institute Expands into New South Lake Union Life Sciences Building

• Posted onSeptember 21, 2022 Last Updated: September 21, 2022
• By: Kaitlyn Grosse

News

Shape Therapeutics Included in Fierce Biotech’s 2022 Fierce 15

• Posted onSeptember 21, 2022 Last Updated: September 21, 2022
• By: Kaitlyn Grosse

Funding

Largest Gift in Fred Hutch History: $78M from Stuart and Molly Sloan Will Support Precision Oncology

• Posted onSeptember 13, 2022 Last Updated: September 13, 2022
• By: Kaitlyn Grosse

Funding

Good Therapeutics Being Acquired by Roche for $250M

• Posted onSeptember 13, 2022 Last Updated: September 13, 2022
• By: Kaitlyn Grosse

News

Ora Biomedical Plans New Drug-Discovery Facility in Seattle Area

• Posted onSeptember 7, 2022 Last Updated: September 7, 2022
• By: Kaitlyn Grosse

Funding

With $50M, Vilya’s Peptides Aim to Transcend Cells’ Lipid Membrane

• Posted onSeptember 7, 2022 Last Updated: September 7, 2022
• By: Kaitlyn Grosse